Intestinal Permeability of Forskolin by In Situ Single Pass Perfusion in Rats

Abstract

The intestinal permeability of forskolin was investigated using a single pass intestinal perfusion (SPIP) technique in rats. SPIP was performed in different intestinal segments (duodenum, jejunum, ileum, and colon) with three concentrations of forskolin (11.90, 29.75, and 59.90 µg/mL). The investigations of adsorption and stability were performed to ensure that the disappearance of forskolin from the perfusate was due to intestinal absorption. The results of the SPIP study indicated that forskolin could be absorbed in all segments of the intestine. The effective permeability (P_eff) of forskolin was in the range of drugs with high intestinal permeability. The P_eff was highest in the duodenum as compared to other intestinal segments. The decreases of P_eff in the duodenum and ileum at the highest forskolin concentration suggested a saturable transport process. The addition of verapamil, a P-glycoprotein inhibitor, significantly enhanced the permeability of forskolin across the rat jejunum. The absorbed fraction of dissolved forskolin after oral administration in humans was estimated to be 100 % calculated from rat P_eff. In conclusion, dissolved forskolin can be absorbed readily in the intestine. The low aqueous solubility of forskolin might be a crucial factor for its poor oral bioavailability.

Key words

forskolin - intestine - permeability - single pass perfusion - Plectranthus barbatus - Coleus forskohlii - Lamiaceae

References

• 1 Alasbahi R H, Melzig M F. Plectranthus barbatus: a review of phytochemistry, ethnobotanical uses and pharmacology – Part 1.  Planta Med. 2010;  76 653-661
• 2 Alasbahi R H, Melzig M F. Plectranthus barbatus: a review of phytochemistry, ethnobotanical uses and pharmacology – Part 2.  Planta Med. 2010;  76 753-765
• 3 Kavitha C, Rajamani K, Vadive E. Coleus forskohlii: a comprehensive review on morphology, phytochemistry and pharmacological aspects.  J Med Plants Res. 2010;  4 278-285
• 4 Guo J F, Lu B, Meng F H, Zhao Y M. Liquid chromatography tandem mass spectrometric assay for the determination of forskolin in rat plasma.  Chin J Anal Chem. 2009;  37 399-402
• 5 Zakeri-Milani P, Valizadeh H, Tajerzadeh H, Azarmi Y, Islambolchilar Z, Barzegar S, Barzegar-Jalali M. Predicting human intestinal permeability using single-pass intestinal perfusion in rat.  J Pharm Pharm Sci. 2007;  10 368-379
• 6 Jain R, Duwuri S, Kansara V, Mandava N K, Mitra A K. Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats.  Int J Pharm. 2007;  336 233-240
• 7 Salphati L, Childers K, Pan L, Tsutsui K, Takahashi L. Evaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in man.  J Pharm Pharmacol. 2001;  53 1007-1013
• 8 Cao X, Gibbs S T, Fang L, Miller H A, Landowski C P, Shin H C, Lennernas H, Zhong Y, Amidon G L, Yu L X, Sun D. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.  Pharm Res. 2006;  23 1675-1686
• 9 Guide for the care and use of laboratory animals, 8th edition. Washington DC: The National Academies Press; 2010: 11-40
• 10 Cook T J, Shenoy S S. Intestinal permeability of chlorpyrifos using the single-pass intestinal perfusion method in the rat.  Toxicology. 2003;  184 125-133
• 11 Issa C, Gupta P, Bansal A K. Implications of density correction in gravimetric method for water flux determination using rat single-pass intestinal perfusion technique: a technical note.  AAPS PharmSciTech. 2003;  4 44-49
• 12 Nagare N, Damre A, Singh K S, Mallurwar S R, Iyer S, Naik A, Chintamaneni M. Determination of site of absorption of propranolol in rat gut using in situ single-pass intestinal perfusion.  Indian J Pharm Sci. 2010;  72 625-629
• 13 Fagerholm U, Lennernäs H. Experimental estimation of the effective unstirred water layer thickness in the human jejunum, and its importance in oral drug absorption.  Eur J Pharm Sci. 1995;  3 247-253
• 14 Morris D I, Greenberger L M, Bruggemann E P, Cardarelli C, Gottesman M M, Pastan I, Seamon K B. Localization of the forskolin labeling sites to both halves of P-glycoprotein: similarity of the sites labeled by forskolin and prazosin.  Mol Pharmacol. 1994;  46 329-337
• 15 Morris D I, Speicher L A, Ruoho A E, Tew K D, Seamon K B. Interaction of forskolin with the P-glycoprotein multidrug transporter.  Biochemistry. 1991;  30 8371-8379
• 16 Thiebaut F, Tsuruo T, Hamada H, Gottesman M M, Pastan I, Willingham M C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.  Proc Natl Acad Sci USA. 1987;  84 7735-7738
• 17 Miyamoto K I, Koga-Takeda K, Koga K, Ohshima T, Nomura M. Saturable function of P-glycoprotein as a drug-efflux pump in multidrug-resistant tumour cells.  J Pharm Pharmacol. 1996;  48 522-525
• 18 MacLean C, Moenning U, Reichel A, Fricker G. Closing the gaps: a full scan of the intestinal expression of p-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in male and female rats.  Drug Metab Dispos. 2008;  36 1249-1254
• 19 Fagerholm U, Johansson M, Lennernäs H. Comparison between permeability coefficients in rat and human jejunum.  Pharm Res. 1996;  13 1336-1342
• 20 Lennernäs H. Animal data: the contributions of the Ussing Chamber and perfusion systems to predicting human oral drug delivery in vivo.  Adv Drug Deliv Rev. 2007;  59 1103-1120
• 21 Sandström R, Karlsson A, Knutson L, Lennernäs H. Jejunal absorption and metabolism of R/S-verapamil in humans.  Pharm Res. 1998;  15 856-862